Objectives: The prevalence and importance of early right ventricular dysfunction and pulmonary hypertension in pediatric acute respiratory distress syndrome are unknown. We aimed to describe the prevalence of right ventricular dysfunction and pulmonary hypertension within 24 hours of pediatric acute respiratory distress syndrome diagnosis and their associations with outcomes. Design: Retrospective, single-center cohort study. Setting: Tertiary care, university-affiliated PICU. Patients: Children who had echocardiograms performed within 24 hours of pediatric acute respiratory distress syndrome diagnosis. Interventions: None. Measurements and Main Results: Between July 1, 2012, and June 30, 2016, 103 children met inclusion criteria. Echocardiograms were analyzed using established indices of right ventricular and left ventricular systolic function and for evidence of pulmonary hypertension. Echocardiographic abnormalities were common: 26% had low right ventricular fractional area change, 65% had low tricuspid annular plane systolic excursion, 30% had low left ventricular fractional shortening, and 21% had evidence of pulmonary hypertension. Abnormal right ventricular global longitudinal strain and abnormal right ventricular free wall strain were present in 35% and 40% of patients, respectively. No echocardiographic variables differed between or across pediatric acute respiratory distress syndrome severity. In multivariable analyses, right ventricular global longitudinal strain was independently associated with PICU mortality (odds ratio, 3.57 [1.33-9.60]; p = 0.01), whereas right ventricular global longitudinal strain, right ventricular free wall strain, and the presence of pulmonary hypertension were independently associated with lower probability of extubation (subdistribution hazard ratio, 0.46 [0.26-0.83], p = 0.01; subdistribution hazard ratio, 0.58 [0.35-0.98], p = 0.04; and subdistribution hazard ratio, 0.49 [0.26-0.92], p = 0.03, respectively). Conclusions: Early ventricular dysfunction and pulmonary hypertension were detectable, prevalent, and independent of lung injury severity in children with pediatric acute respiratory distress syndrome. Right ventricular dysfunction was associated with PICU mortality, whereas right ventricular dysfunction and pulmonary hypertension were associated with lower probability of extubation. (Crit Care Med 2018; 46:e1055-e1062) 
dysfunction and/or pulmonary hypertension (PH) can worsen oxygenation via pulmonary ventilation-perfusion mismatching and may contribute to nonpulmonary organ failure.
In adult acute respiratory distress syndrome (ARDS), a spectrum of acute RV dysfunction severity is recognized with a prevalence anywhere from 20% to 50% during the course of ARDS (7) (8) (9) (10) (11) (12) (13) , which increases the risk for systemic circulatory failure, shock (8, 9) , and mortality (9, (11) (12) (13) . Pulmonary hypertension, a risk factor for RV dysfunction, has been described in pediatric patients with severe acute hypoxemic respiratory failure (14, 15) and, when present beyond 36 hours of diagnosis, is associated with mortality (14) .
Echocardiography is a noninvasive, readily available bedside tool that can detect the presence of PH and measure ventricular systolic function. Although RV systolic function can be assessed by various qualitative and quantitative variables, the use of speckle tracking echocardiography (STE) has emerged in recent years as an insonation angle-independent measure of RV systolic function (16) (17) (18) (19) . STE allows for the assessment of longitudinal RV deformation as a percentage of myocardial fiber shortening (more negative values reflect better systolic function) (17) (18) (19) and may allow for earlier, more accurate detection of RV dysfunction (19) (20) (21) .
The prevalence and importance of early RV dysfunction and PH in PARDS are unknown, and the role of echocardiography in these patients is ill defined. This retrospective cohort study aimed to assess the prevalence of RV dysfunction and PH within 24 hours of PARDS diagnosis. We hypothesized that early RV dysfunction and PH would be associated with greater PARDS severity, higher mortality, and longer duration of mechanical ventilation.
MATERIALS AND METHODS

Study Design and Patient Selection
This retrospective cohort study of an ongoing prospective study was approved by the Children's Hospital of Philadelphia's (CHOP) Institutional Review Board with a waiver of the need for informed consent. The cohort was derived from a previously described PARDS database (2) of prospectively enrolled intubated children admitted to the CHOP PICU between July 1, 2012, and June 30, 2016. The American-European Consensus Conference criteria (22) were used for database enrollment but all subjects also met Berlin (23) and Pediatric Acute Lung Injury Consensus Conference (PALICC) criteria (24) . Patients were included if they had a clinically performed echocardiogram within 24 hours of PARDS diagnosis with recorded images of sufficient quality for RV strain analyses.
Data Collection
Data that was prospectively collected following inclusion in the PARDS database has been previously described (2) . Briefly, these data included demographics, measures of oxygenation at various time points, use of ancillary therapies within 72 hours, any use of extracorporeal membrane oxygenation (ECMO), Pediatric Risk of Mortality (PRISM) III score at 12 hours, and patient outcomes. Charts were retrospectively reviewed to determine inhaled nitric oxide (iNO) use, vasopressor/ inotrope use, and ventilator settings at the time of echocardiogram as well as plasma B-type natriuretic peptide (BNP) concentrations measured within 24 hours of echocardiogram.
Echocardiographic Measurements
Echocardiograms were analyzed by a trained cardiologist (Y.W.) blinded to patient history and outcome. Echocardiographic indices of RV systolic function included qualitative assessment (normal or mildly, moderately, or severely diminished), fractional area change (FAC), tricuspid annular plane systolic excursion (TAPSE), and myocardial performance index. STE analyses included RV peak systolic global longitudinal strain (GLS) and strain rate as well as the RV free wall peak systolic longitudinal strain (free wall strain [FWS] ) and strain rate. Left ventricular (LV) systolic function was assessed using qualitative assessment (see RV above) and LV fractional shortening (LV FS). PH was assessed using ventricular septal position, tricuspid regurgitant velocity, pulmonary artery acceleration time (PAAT), and RV ejection time. RV dilation was assessed qualitatively. TAPSE was measured either via M-mode interrogation of the lateral portion of the tricuspid valve annulus or, if M-mode imaging was not available, by offline measurement of the displacement of the tricuspid valve from the apical four-chamber view images (25) . Strain analyses were performed using postprocessing software (TomTec; Cardiac Performance Analysis, Munich, Germany). The apical four-chamber view was used to measure the strain and strain rate values. Control values for RV strain and strain rate data were obtained from 60 echocardiograms performed on healthy pediatric patients of representative age groups identified in the CHOP Echolab digital system.
Definitions
Abnormal TAPSE was defined as a value less than -2 sds below published pediatric normal values for age (26) . Absolute TAPSE z scores were calculated with an online calculator (parameterz.blogspot.com). Abnormal FAC was defined as less than 35%. Evidence of PH was defined as abnormal septal position given that only about 5% of the studies had images of sufficient quality for accurate measurement of the tricuspid regurgitation (TR) jet and PAAT. Abnormal GLS and FWS were defined as less than -2 sd below the internal controls: for GLS, this was considered a value greater than -18.2%; for FWS, this was considered a value greater than -21.4%. Abnormal LV FS was defined as less than 28%. Oxygenation index (OI) was defined as mPaw × Fio 2 × 100/Pao 2 , where mPaw is mean airway pressure. PARDS severity was defined using worst OI in the first 24 hours of PARDS (2) according to PALICC categories (mild OI 4 to < 8; moderate OI 8 to < 16; severe OI ≥ 16) (24) . A patient was identified as "immunocompromised" in the presence active immunosuppressive therapy or a congenital immunodeficiency (27) . All mention of "ventilation" indicates invasive ventilation; noninvasive ventilation was not counted. "Day 1" was initiation of invasive ventilation. Liberation from invasive ventilation greater than or equal to 24 hours defined duration of ventilation. Patients requiring reinitiation of invasive ventilation had the extra days counted toward total ventilator days. Ventilator-free days (VFDs) was determined by subtracting total ventilator days from 28 in survivors. Patients with greater than or equal to 28 ventilator days and PICU nonsurvivors were assigned VFD equals to 0. Intrarater reliability for the echocardiogram interpretations was determined with repeated measurements in 20 subjects greater than 2 months after initial interpretation. Intraclass correlation coefficients (ICCs) were used to assess continuous measurements whereas weighted kappa was used for categorical measurements. Variable reproducibility was graded as acceptable (R > 0.6), good (R > 0.7), or excellent (R > 0.8).
Data Analysis
To test for independent association between echocardiography variables and PICU mortality, logistic regression was performed upon each variable, adjusting for PRISM III, and worst OI in the first 24 hours. We have previously demonstrated the association between PRISM III and worst OI and outcomes in PARDS (2, 28, 29) . As there were a limited number of deaths, we avoided fitting additional variables for concern of overfitting. Immunocompromised status was also assessed but did not improve fit of any model by likelihood ratio testing and so was not included in the final model. The final fit of each model was assessed using the Hosmer-Lemeshow test.
To assess the independent association with probability of extubation, we performed competing risk regression, using successful extubation as the primary outcome, and death as the competing risk. Observations were censored at 28 days, making this outcome comparable to VFD at 28 days. Fine and Gray (30) competing risk regression calculates a subdistribution hazard ratio (SHR) for risk of extubation, accounting for the competing risk of death. The SHR is affected by the probability of extubation (primary outcome), time to extubation, and probability of death (competing event). As for mortality, SHR are adjusted for PRISM III and worst OI. The proportional hazards assumption was assessed by testing for interaction with a time-dependent covariate.
RESULTS
One-hundred three patients met inclusion criteria, which represents 29% of all patients with PARDS during the study time period; 14% met criteria for mild, 35% for moderate, and 51% for severe PARDS. Patients who met inclusion criteria had more severe illness, a higher rate of immunocompromised comorbidities, and higher iNO utilization compared with database patients that were excluded ( Table 1 and Supplemental Table 1 , Supplemental Digital Content 1, http://links. lww.com/CCM/D918). Infectious causes of PARDS, defined as infectious pneumonia and sepsis, accounted for 73% of the diagnoses. Preexistent PH was present in seven patients (7%) with three patients actively receiving preillness sildenafil therapy. Invasive mechanical ventilation support characteristics at the time of echocardiogram were available in a subset of patients (89%) and notable for a lower OI at the time of echocardiogram compared with the worst OI in 24 hours (p < 0.001) (Supplemental Table 2 , Supplemental Digital Content 2, http://links.lww.com/CCM/D919). PICU mortality was 27% ( Table 1) .
Prevalence of Echocardiography Measurements
At the time of echocardiogram, 31 patients (30%) were receiving iNO, which was more common among patients with severe PARDS compared with those categorized as mild or moderate PARDS (Fisher exact p = 0.002). Fifty-seven patients (55%) were on inotropic and/or vasopressor support at the time of echocardiogram, and this was not different between or across PARDS severity (Fisher exact p = 0.79; Cuzick p = 0.66). The overall rates of FAC less than 35% were 26%, evidence of PH was 21%, and LV FS less than 28% was 30%. Abnormal RV GLS and FWS were observed in 35% and 40%, respectively. The median TAPSE z score for the entire cohort was -2.97 (IQR, -5.53 to -1.12) with 65% having TAPSE z score less than -2 sd for age. There were no significant differences between various echocardiography measures of RV and LV systolic function, PH, or qualitative RV dilation between or across severity of PARDS when characterized by worst OI in the first 24 hours following PARDS diagnosis or when stratified by iNO exposure at the time of echocardiogram ( Table 2; and Supplemental Table 3 , Supplemental Digital Content 3, http://links.lww.com/CCM/D920). There was a trend toward longer duration of MV and reduced VFD at 28 days with worse PARDS severity and with iNO exposure at the time of echocardiogram (Supplemental Table 4 
Associations of Patient Outcomes
Abnormal RV GLS within the first 24 hours was independently associated with PICU mortality, both in the overall cohort and when restricted to those not exposed to iNO at the time of echocardiogram. Other echocardiogram variables of RV systolic function, LV systolic function, or PH were not associated with mortality (Tables 3 and 4) .
Abnormal RV GLS, abnormal RV FWS, and PH were independently and inversely associated with the probability of successful extubation (Table 3 and Fig. 1) . When restricted to the subgroup of patients not exposed to iNO, RV GLS, and PH (but not RV FWS) were independently and inversely associated with the probability of successful extubation ( Table 4) .
Subgroup multivariate analyses excluding patients with preexisting PH and for the subgroups of patients with conventional ventilator variables at the time of echocardiogram showed similar results with respect to RV GLS and PH associations with outcomes (Supplemental Table 6 
BNP Correlations
BNP was available for a subset of patients (Table 1) 
DISCUSSION
This study demonstrated that echocardiographic evidence of RV and LV systolic dysfunction and PH were prevalent within 24 hours of PARDS diagnosis. RV GLS was independently associated with PICU mortality, whereas RV GLS, RV FWS, and the presence of PH were independently associated with lower probability of extubation in PARDS patients. Abnormalities in RV and LV function appeared to be independent of PARDS severity in this group of patients. 
4 (29) 12 (33) 20 (38) 36 ( We found that up to 40% of patients had echocardiographic evidence of RV systolic dysfunction and 21% had PH early in their course of PARDS, even with use of iNO and/or inotropes/vasopressors in a significant proportion of patients. These results are similar to those reported in adult studies (7-13).
In adult ARDS, RV dysfunction can vary from mild, with modest changes in TAPSE, to severe cases of acute cor pulmonale (7, 8, 31) . Furthermore, TAPSE has been shown to correlate with severity of ARDS and increased 30-day mortality (12) . Contrary to these findings, we found no correlation Figure 1 . Probability of successful extubation accounting for the competing risk of death after adjustment for Pediatric Risk of Mortality III and worst oxygenation index within the first 24 hr following pediatric acute respiratory distress syndrome (PARDS) diagnosis for A, abnormal versus normal right ventricle (RV) global longitudinal strain (GLS) (n = 103); B, abnormal versus normal RV free wall strain (FWS) (n = 103); and C, echocardiographic evidence of pulmonary hypertension (PH) (n = 94). Abnormal RV GLS and RV FWS were defined as less than -2 sd compared with healthy internal controls: for GLS, this was considered a value greater than -18.2%; for FWS, this was considered a value greater than -21.4%. between early TAPSE z scores with PARDS severity (Table 2) or with mortality or probability of extubation (Tables 3 and 4) . One of the limitations of TAPSE is that it can be affected by LV contractility (32) . Indeed, in our study, TAPSE z scores correlated just as well with LV FS (ρ = 0.54; p < 0.0001) as with RV GLS (ρ = -0.53; p < 0.0001), RV FWS (ρ = -0.51; p < 0.0001), and less so with RV FAC (ρ = 0.46; p < 0.0001). This, along with the fact that the 30% of our population had abnormal LV systolic function, suggests that early TAPSE z scores may not discriminate degrees of RV dysfunction in PARDS patients. Strain echocardiography has allowed for earlier and more accurate detection of acute RV dysfunction in various populations (19) (20) (21) . In our study, we found abnormal strain to be more commonly detected than low FAC. We found that diminished RV GLS was the only echocardiographic variable of ventricular function that was associated with increased PICU mortality; diminished RV GLS and RV FWS were both associated with lower probability of extubation. Despite the fact that RV dysfunction is prevalent in pediatric and adult ARDS, no studies to our knowledge have examined strain as a measure of function that is potentially superior to other standard measures, such as TAPSE and FAC. There is very likely a spectrum of RV dysfunction in PARDS patients that changes with time and future research should focus on better defining this spectrum based on echocardiographic variables, including TAPSE and strain echocardiography, as well as other patient characteristics and biomarkers.
BNP, and its precursor N-terminal prohormone BNP, are well-studied plasma biomarkers of cardiac dysfunction (33) . However, these substances may also be expressed in and released from inflamed lung (33) . There is conflicting data in adult ARDS about the utility of BNP as a marker of RV dysfunction and in predicting mortality (33) (34) (35) (36) . Contrary to the only report of BNP levels in children with acute lung injury (37), we found that BNP concentration within the first 24 hours of PARDS diagnosis was not associated with patient outcomes and correlated best with LV FS. Despite its wide clinical use, BNP may not accurately reflect RV dysfunction in the setting of acute noncardiac organ damage and inflammation such as in PARDS.
The presence and persistence of PH in pediatric nonsurvivors of pediatric patients with acute hypoxemic respiratory failure was demonstrated when pulmonary artery catheters were routinely used and prior to current PARDS management strategies (14, 15) . Acute RV dysfunction in PARDS can have multifactorial etiologies, including PH, systemic inflammatory and other neurohumoral processes, or disease-related primary LV dysfunction with systemic hypotension that can compromise RV function (38, 39) . In addition, acute RV dysfunction can cause LV dysfunction by ventricular interdependence mechanisms (38) . As morbidity and mortality in PARDS is driven by the development of MODS (1-6), future clinical and translational research should address interventions and therapies that identify (i.e., echocardiography) and treat early modifiable hemodynamic risk factors (including PH, RV and LV dysfunction) that may prevent or mitigate the development or progression of MODS.
This single-center, retrospective cohort study has several limitations. Inherent in any retrospective study, causality cannot be determined, and associations that we found to patient outcomes are limited by lack of defined criteria for variables such as inotrope/vasopressor use and extubation. Our institutional practice is to initiate iNO at 20 ppm for hypoxemia associated with PARDS. However, it is difficult to know exactly from the medical records if or when iNO therapy was used solely to treat PH. For example, six of seven patients with history of PH were started on iNO prior to an echocardiogram being performed, and only four had severe PARDS. The included patients had higher disease severity and were a subset of PARDS patients admitted over the study time period (Supplemental Table 1 , Supplemental Digital Content 1, http://links.lww.com/CCM/D918). We characterized PARDS severity by worst OI in 24 hours and, for many patients including subjects in this study, OI will improve by 24 hours (Table 1) . Although OI at 24 hours may better discriminate mortality in isolation (2), we characterized PARDS severity by worst OI in 24 hours so as to mitigate effects of patient management decisions made after the echocardiogram was performed, including initiation of iNO if PH or RV dysfunction was observed. Echocardiogram images were obtained for clinical purposes using undefined criteria. These factors likely introduce confounding by indication since there was likely a clinical reason for obtaining an echocardiogram for most patients. Patients did not undergo a standard image acquisition protocol, and, subsequently, accurate RV pressure estimates were only obtained in a small minority of patients. In addition, assessment of the RV by echocardiography is often challenging, especially in patients with significant lung disease. We only included echocardiograms with apical four-chamber windows that were of sufficient quality to accurately perform RV strain analyses which introduces some selection bias. Pre-PARDS echocardiograms were not evaluated in this study as none existed in the vast majority. Finally, the high use of iNO and inotropes/vasopressors may have treated some PH, RV dysfunction, or LV dysfunction that otherwise would have been detected with echocardiography and therefore would have biased our result toward the null.
CONCLUSIONS
In conclusion, our data suggest that RV and LV systolic dysfunction and PH are prevalent in PARDS and detectable by echocardiography within 24 hours of PARDS diagnosis. These abnormalities are independent of PARDS severity. Early abnormal RV GLS is associated with PICU mortality whereas early abnormal RV GLS, abnormal RV FWS, and PH are associated with decreased probability of extubation. Our results should inform future studies for targeted detection and treatment of ventricular dysfunction and PH in PARDS patients with the potential for patient stratification based on early and evolving hemodynamic profiles.
